Seeking efficiency in executive compensation benchmarking?

Unlock Efficiency in Executive Compensation Benchmarking with CompAnalyst Executive

CompAnalyst Executive

The charts on this page feature a breakdown of the total annual pay for the top executives at DEXCOM INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. DEXCOM INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. DEXCOM INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Kevin Sayer
Chairperson, President & Chief Executive Officer
Total Cash $2,204,794 Equity $13,212,746 Other $18,112 Total Compensation $15,435,652
Jacob S. Leach
EVP, Chief Operating Officer
Total Cash $971,896 Equity $3,433,079 Other $22,233 Total Compensation $4,427,208
Jereme M. Sylvain
EVP, Chief Financial Officer
Total Cash $792,203 Equity $2,697,743 Other $48,935 Total Compensation $3,538,881
Michael J. Brown
EVP, Chief Legal Officer
Total Cash $894,061 Equity $4,824,782 Other $27,435 Total Compensation $5,746,278
Girish Naganathan
EVP, Chief Technology Officer
Total Cash $419,096 Equity $3,627,611 Other $4,824 Total Compensation $4,051,531
For its 2022 fiscal year, DEXCOM INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Kevin Sayer CEO Pay $15,435,652 Median Employee Pay $65,706 CEO Pay Ratio 235:1
For its 2022 fiscal year, DEXCOM INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Barbara E. Kahn Total Cash $319,299
Bridgette P. Heller Total Cash $317,371
Eric J. Topol, M.D. Total Cash $317,371
Jay S. Skyler, M.D. Total Cash $311,268
Karen Dahut Total Cash $317,050
Kyle Malady Total Cash $314,480
Mark G. Foletta Total Cash $360,416
Nicholas Augustinos Total Cash $319,299
Richard A. Collins Total Cash $317,050
Steven R. Altman Total Cash $314,480

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.